BiologicsHQ Search

Information contained in the Venable BiologicsHQ database relates to FDA-approved drug products listed in the CDER Purple Book and FDA-approved cellular and gene therapy products. Product and Company page search results are reported for FDA-approved indications, aBLA and 505(b)(2) activity, approved foreign biosimilars, IPRs, PGRs and U.S. litigations.

ABBOTTABBVIEABLYNXACCORDACENDIS PHARMAADAPTIMMUNEADC THERAPEUTICSADVANCE BIOFACTURESAKORNALEXIONALLERGANALLERQUESTALLOCORDALTOR BIOSCIENCEALVOGENALVOTECHAMBIOAMGENAMICUS THERAPEUTICSAMNEALAMPHASTARAMYLIN PHARMSANTARESAPOTEXARGENXASTELLASASTRAZENECAAUXILIUMAVENTISBAUSCH AND LOMBBAXALTABAXTER HEALTHCAREBAYER HEALTHCAREBECTON DICKINSONBEIGENEBERLEX LABSBIO-THERABIOCONBIOEQBIOGENBIOMARINBIOVERATIVBIOVEXBIOVITRUMBLOODWORKSBLUEBIRD BIOBOEHRINGER INGELHEIMBRISTOL-MYERS SQUIBBBTG INTERNATIONALCABARETCELGENECELLTECHCELLTRANSCELLTRIONCENTUSCHENGDU KANGHONGCHIESICHIRONCHONG KUN DANGCHUGAICIPLACIS BIOCITIUSCLEVELAND CORD BLOOD CENTERCLINIMMUNE LABS, UNIVERSITY OF COLORADO CORD BLOOD BANKCOHERUS BIOSCIENCESCREALTA PHARMSCREATIVE BIOLABSCSL BEHRINGCYTOGENDAIICHI SANKYODENDREONDIGESTIVE CAREDOMPE FARMACEUTICIDR REDDYSDRAXIMAGEDUKE UNIVERSITY SCHOOL OF MEDICINEDYAXEIRGENIXEISAIEKR THERAPEUTICSELAN PHARMACEUTICALSELI LILLYELUSYS THERAPEUTICSEMD SERONOENDOENZYVANT THERAPEUTICSEVIVE BIOTECHNOLOGYEVOLUSFERRINGFIBROCELL TECHNOLOGIESFORMYCONFRESENIUS KABIFUJI PHARMAFUJIFILMGALDERMAGAMIDA CELLGENENTECHGENMABGENZYMEGILEADGLAXOSMITHKLINEHALOZYME THERAPEUTICSHORIZON THERAPEUTICSHOSPIRAHUGELHUMAN GENOME SCIENCESHYCLONE LABORATORIESIMCLONEIMMUNEXIMMUNOCOREIMMUNOGENIMMUNOMEDICSINCYTEINTERFERON SCIENCESIOVANCEIPSENIPSEN BIOPHARMISO TEXJANSSEN (CENTOCOR)JAZZ PHARMACEUTICALSJOHNSON AND JOHNSONJUNOJUNO THERAPEUTICSKASHIV BIOSCIENCES (ADELLO)KITE PHARMAKLINGE BIOPHARMAKRYSTAL BIOTECHKYOWA KIRINLEADIANT BIOSCILEK PHARMACEUTICALSLEO PHARMALIFESOUTH COMMUNITY BLOOD CENTERSLINDIS BIOTECHLUNDBECK SEATTLE BIOPHARMACEUTICALSLUPINMABXIENCEMACROGENICSMANNKINDMD ANDERSON CORD BLOOD BANKMEDIMMUNEMEDIWOUNDMEDY-TOXMEITHEAL PHARMACEUTICALSMERCKMERZ PHARMSMILTENYIMOCHIDAMOMENTA PHARMACEUTICALSMORPHOSYSMYLANNEKTARNESTLE SKIN HEALTHNEW YORK BLOOD CENTERNOVARTISNOVEXNOVIMMUNENOVO NORDISKNPS PHARMSOMJ PHARMACEUTICALSONO PHARMACEUTICALONYORCHARD THERAPEUTICSORGANOGENESISORGANONORTHO-MCNEILOSSIFI-MABOUTLOOK THERAPEUTICSPFENEXPFIZERPHARMACIAPHARMAESSENTIAPHIGENIXPOLPHARMAPRESTIGEPROVENTION BIOQILUQOL MEDICALREGENERONREGENXBIOREVANCE THERAPEUTICSRIDGEBACK BIOTHERAPEUTICSROCHE (HOFFMANN-LA ROCHE)SAMILSAMSUNG BIOEPISSAN ROCCO THERPEUTICSSANDOZSANOFISAREPTA THERAPEUTICSSCHERINGSEAGEN (SEATTLE GENETICS)SERVIER PHARMASHANGHAI HENLIUS BIOTECHSHIRESIGMA TAUSLOAN KETTERINGSPARK THERAPEUTICSSPECTRUMSTADASTEMLINE THERAPEUTICSSTRATATECHSUN PHARMASWISS PHARMA INTERNATIONALTAIMED BIOLOGICSTAKEDA PHARMSTANVEXTASUKU HONJOTEVATG THERAPEUTICSTHERATECHNOLOGIESTHROMBOGENICSUCBULTRAGENYXUNICUREUNIGENEUNITED THERAPEUTICSUPSHER-SMITHVALEANTVERICELVERTEXVIATRISVIDARA THERAPEUTICS RESEARCHVIELA BIOVIOKACEVIVUSWILSON WOLF MANUFACTURINGWYETHXBRANEY-MABS THERAPEUTICSYEDA

Methodology

Information contained in the Venable BiologicsHQ database relates to FDA-approved drug products listed in the CDER Purple Book or on the FDA website (www.fda.gov). Information relating to FDA licensed products, FDA-approved indications, and aBLA and 505(b)(2) applications is obtained from public sources including the U.S. FDA website (www.fda.gov). Information relating to litigations is given only for cases active from January 31, 2010 onward. Information relating to foreign biosimilar / biologics follow-on products approved in Australia, Canada, the E.U., Japan and South Korea is from public sources. Statistics graphics are compiled from information contained in the Venable BiologicsHQ database.

Disclaimer

The individuals who maintain this site work for Venable LLP. The information, comments and links posted on this site do not constitute legal advice. No attorney-client relationship has been or will be formed by any communication(s) to, from or with the site and/or the author. For legal advice, contact an attorney at Venable LLP or an attorney actively practicing in your jurisdiction. Do not send any confidential or privileged information to the author; neither Venable LLP nor the author will assume any liability or responsibility for it. If you send any information, documents or materials to the site, you give permission for the author to include them on or in the site. No information, documents or materials you send to the site will be considered confidential or privileged by Venable LLP or its lawyers. Also, no such information, documents or materials will be returned to you. All decisions relating to the content belong to the author.

Subscribe for Future Updates

    captcha